Details of the Drug Metabolized by Drug-Metabolizing Enzyme (DME)
General Information of Drug (ID: DR0769) | ||||||
---|---|---|---|---|---|---|
Drug Name |
Org-33062
|
|||||
Synonyms |
Gepirona; Gepirona [Spanish]; Gepirone; Gepirone ER; Gepirone [INN]; Gepironum; Gepironum [Latin]; JW5Y7B8Z18; MJ 13805; MJ 13805-1; MJ-13805; Travivo; Variza; gepiron ER; 2,6-Piperidinedione, 4,4-dimethyl-1-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-; 4,4-Dimethyl-1-(4-(4-(pyrimidin-2-yl)piperazin-1-yl)butyl)piperidine-2,6-dione; 4,4-dimethyl-1-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]piperidine-2,6-dione; 83928-76-1; AC1L1IK6; AC1Q6F8Q; AK115965; Ariza; BMY 13805; BMY-13805; CHEMBL284092; UNII-JW5Y7B8Z18
|
|||||
Indication | Cocaine addiction [ICD11: 6C45] | Phase 2 | [1] | |||
Structure | ||||||
3D MOL | 2D MOL | |||||
Pharmaceutical Properties | Molecular Weight | 359.5 | Topological Polar Surface Area | 69.6 | ||
Heavy Atom Count | 26 | Rotatable Bond Count | 6 | |||
Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 6 | |||
Cross-matching ID |
|
|||||
The Metabolic Roadmap of This Drug | |||||
---|---|---|---|---|---|
The Full List of Drug Metabolites (DM) of This Drug | ||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
The Full List of Metabolic Reaction (MR) of This Drug | ||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
||||||||||||||||||||||||||||||||||||||||||||||
Drug-Metabolizing Enzyme(s) (DME) Metabolizing This Drug | ||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.